Quarterly pharmacy formulary change notice

Similar documents
Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Health Partners Medicare Prime 2019 Formulary Changes

HEALTH SHARE/PROVIDENCE (OHP)

Emblem Medicaid 3Q18 Formulary Updates

UPDATE Ohana QUEST Integration Medicaid

Aetna Better Health of Illinois Medicaid Formulary Updates

2018 CareOregon Advantage Part D Formulary Changes

Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates

Quarterly pharmacy formulary change

Alameda Alliance for Health Pharmacy & Therapeutics (P&T) Committee Decisions

WellCare s South Carolina Preferred Drug List Update

Quarterly Pharmacy Formulary Change Notice

Upper Peninsula Health Plan Advantage (HMO) (List of Covered Drugs)

HOW TO USE THE FORMULARY

Quarterly pharmacy formulary change notice

PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary April 1, 2018 Updates. Formulary Alternatives

These programs and quantity limitations may not apply. Check your certificate or other plan information for benefit details.

Quarterly pharmacy formulary change notice

UPDATE WellCare s South Carolina

MEDICAID PROVIDER BULLETIN December 2017 Quarterly pharmacy formulary change notice. Effective for all patients on February 1, 2018

Step Therapy Requirements. Effective: 11/01/2018

Aspirin. Iron Supplements

Quarterly pharmacy formulary change notice

Step Therapy Requirements. Effective: 05/01/2018

WellCare Signature (PDP) and WellCare Classic (PDP) Formulary Addendum

Your prescription benefit updates Formulary Updates - Effective January 1, 2019

Acyclovir Ointment. Aetna Better Health Pennsylvania. Products Affected. acyclovir ointment 5 % external Details. Criteria

Quarterly pharmacy formulary change notice

PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES

Step Therapy Requirements

PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary April 1, 2018 Updates. Formulary Alternatives

Provider update: Quarterly pharmacy formulary change notice

ANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria

THERAPEUTIC AREA NAME STRENGTH DOSAGE FORM

Memorial Hermann Advantage HMO February 2019 Formulary Addendum

Calgary Long Term Care Formulary

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

PDP Classic Formulary Addendum

JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET BYDUREON BCISE 2 MG/0.

Rationale for Decision Excluded Generic OTC equivalent available (Flonase Allergy Relief) Medicare status (if differs)

SASKATCHEWAN FORMULARY BULLETIN Update to the 62nd Edition of the Saskatchewan Formulary

Effective for all members on August 1, 2017

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 04/01/2019

Calgary Long Term Care Formulary

Changes to the 2018 BlueCross Secure SM (HMO) & BlueCross Total SM (PPO) Formularies

WellCare s South Carolina Preferred Drug List Update

ANTIEMETICS STEP. Step Therapy Requirements Effective April 1, 2019

Neighborhood Medicaid Formulary Changes: June 2017

You ll find the most up-to-date comprehensive version of our formulary on our website, Click on Drug Finder.

Added, Removed or Changed. Added, Removed or Changed

2018 Formulary Update

THERAPEUTIC AREA NAME STRENGTH DOSAGE FORM

Mercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir

Oregon Health Plan prescription benefit updates

2019 Supplemental Drug List

CMI Marketplace 2015 (List of Covered Drugs)

LET S TALK PREVENTION

Health Partners Medicare Special 2018 Formulary Changes

Peach State Health Plan routinely reviews the medications available on the Preferred Drug

ARBS MEDICATION(S) SUBJECT TO STEP THERAPY DIOVAN HCT MG TAB, DIOVAN HCT MG TABLET

EFFECTIVE 01/04/2019. pimecrolimus 1 % cream (g) - Added to Tier 1 - ST Added: TOPICAL IMMUNOMODULATORS

3 Tier Formulary Additions

2017 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

NOTIFICATION OF FORMULARY CHANGES

Pharmacy Providers and Prescribing Physicians. Updated Over-the-Counter Drug Formulary

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

BLUE SHIELD OF CALIFORNIA JUNE 2016 PLUS DRUG FORMULARY CHANGES

Step Therapy Requirements

Oral Agents. Formulary Limits. Available Strengths. IR: 4mg ER: 12mg Syrup: 2mg/5ml

ADMELOG, NOVOLIN, NOVOLOG, and FIASP

Texas Vendor Drug Program. Formulary Drug Index File Layout. Layout effective: Jul. 2, 2018 Document update: Oct. 1, 2018

Data Class: Internal. 1 inhaler (30 blisters OR 14 blisters institutional pack) per presciption

STEP THERAPY CRITERIA

Amerigroup Washington, Inc. to conduct postservice reviews of certain modifiers and services

STEP THERAPY CRITERIA

Generic (Brand) Strength & Dosage form Fml Limit Cost per Rx Notes 5-HT3 Antagonists

Pharmacy Updates Summary

5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details

Transcription:

Provider Bulletin April 2018 This table is used by HealthKeepers, Inc. to indicate formulary changes applicable to all Anthem HealthKeepers Plus members. These changes were reviewed and approved at the fourth-quarter Pharmacy and Therapeutics Committee meeting. Effective May 1, 2018, formulary changes, nonformulary changes and prior authorization (PA) requirements will apply. Effective for all Anthem HealthKeepers Plus members on May 1, 2018 Therapeutic class INHALED CORTICOSTEROIDS INHALED CORTICOSTEROIDS PROTON PUMP INHIBITORS PROTON PUMP INHIBITORS Medication FLOVENT HFA INHALER FLOVENT DISKUS AEROSPAN 80 MCG INHALER ZEGERID 20 MG OTC ACID REDUCER DR 20 MG CAP OMEPRAZOLE DR 20 MG CAPSULE Formulary status change FOR ALL AGES EFFECTIVE 4/15/18 NON FOR MEMBERS < 6 YEARS OF AGE Potential alternatives (preferred products) ANTICOAGULANTS XARELTO COVERED ANTICOAGULANTS SAVAYSA COVERED MISC ANTINEOPLASTIC KADCYLA ADD PA BULK CHEMICALS COUGH AND COLD COUGH AND COLD CALCIUM CARBONATE POWDER MULTISYMPTOM COLD LIQUID (OTC) MULTISYMPTOM COLD CAPLET/SOFTGEL COLD & ALLERGY ELIXIR (OTC) HYDROXYZINE 50 MG/25 ML SYRUP CYPROHEPTADINE 4 MG/10 ML SYRP OTC GENERIC 12-HR DECONGEST 120 MG CAPLET NON NON https://mediproviders.anthem.com/va HealthKeepers, Inc. is an independent licensee of the Blue Cross and Blue Shield Association. ANTHEM is a registered trademark of Anthem Insurance Companies, Inc AVAPEC-1678-18 April 2018

FOLIC ACID PREPARATION GLP-1 RECEPTOR AGONIST HEPATITIS C HYPERAMMONEMIA IRON REPLACEMENT POTASSIUM REPLACEMENT URINARY PH MODIFIERS L-METHYLFOLATE FORTE 7.5 MG CP L-METHYLFOLATE FORTE 15 MG CAP OZEMPIC SOVALDI SODIUM PHENYLBUTYRATE POWDER SODIUM PHENYLBUTYRATE 500 MG TAB DEXFERRUM 50 MG/ML VIAL DEXFERRUM 100 MG/2 ML VIAL FERRIC X-150 CAPSULE DUOFER 28 MG TABLET FOCALGIN DSS TABLET CHEWABLE IRON 30 MG TABLET POTASSIUM CL ER 8 MEQ CAPSULE POTASSIUM CL ER 20 MEQ TABLET K-SOL 20% (40 MEQ/15 ML) LIQ K-TAB ER 8 MEQ TABLET K-PHOS NEUTRAL TABLET PHOSPHA 250 NEUTRAL TABLET VIRT-PHOS 250 NEUTRAL TABLET Anthem HealthKeepers Plus Page 2 of 5 NON WITH ST AND QL 0.25 MG DOSE; 1 PEN/28 1 MG DOSE; 2 PENS/28 EFFECTIVE 4/1/18 NON WITH PA WITH PA EPCLUSA ZEPATIER PA REQUIRED COD LIVER OIL NON BETA-CAROTENE 25,000 UNITS CAP OTC BETA-CAROTENE 10,000 UNITS CAP OTC NON

Page 3 of 5 ACNE AND ROSACEA AGENTS ACNE AND ROSACEA AGENTS ACNE THERAPY ALZHEIMER'S THERAPY; NMDA RECEPTOR ANTAGONISTS ANTICONVULSANTS ANTICONVULSANTS ANTIEMETICS AND ANTIVERTIGO ANTIEMETICS AND ANTIVERTIGO ANTIMIGRAINE ANTIPARASITICS BRAND OTC VITAMIN A VITAMIN B VITAMIN C VITAMIN D VITAMIN D COMBO VITAMIN E MISCELLANEOUS VITAMINS GENERIC OTC VITAMIN A VITAMIN B VITAMIN C VITAMIN D VITAMIN D COMBO VITAMIN E MISCELLANEOUS NON VITAMINS EDITS NO CHANGES IN /NON STATUS REVISION OR ADDITION TO UM EDIT ONLY MINOLIRA, AKTIPAK DIFFERIN GEL 0.1% GEL, OTC ADAPALENE 0.1% LOTION MEMANTINE HCL 10 MG TABLET APTIOM 200 MG APTIOM 400 MG APTIOM 600 MG APTIOM 800 MG CINVANTI INFUSION VARUBI INJECTION IMITREX 6 MG/0.5 ML VIAL (ML) SOLOSEC ADD ST 45 GMS PER QL REVISED 59 ML PER 30 1 TABLET PER 5 VIALS PER 2 VIALS PER 28 QL REVISION 4 SYRINGES PER 2 G PER FILL; 1 FILL PER 30

Page 4 of 5 DIABETES EPINEPHRINE ERYTHROPOIESIS STIMULATING AGENTS ESTROGENS TRANSDERMAL ESTROGENS TRANSDERMAL GNRH ANALOG HIV ANTIRETROVIRALS HYPERAMMONEMIA IDIOPATHIC PULMONARY FIBROSIS IDIOPATHIC PULMONARY FIBROSIS INHERITED DISORDERS OF METABOLISM COMETRIQ 80 MG VENCLEXTA STARTING PACK VERZENIO BYDUREON BCISE SYMJEPI MIRCERA 30 MCG/0.3 ML 150 MCG/0.3 ML ESTRADIOL TDS PATCH ESTRADIOL PATCH MENOSTAR PATCH VIVELLE-DOT PATCH MINIVELLE PATCH CLIMARA PATCH ALORA PATCH MENOSTAR PATCH VIVELLE-DOT PATCH MINIVELLE PATCH CLIMARA PATCH ALORA PATCH TRIPTODUR ISENTRESS HD RAVICTI ESBRIET 267 MG TABLET ESBRIET 801 MG BUPHENYL 250 GM POWDER 1 CAPSULE 1 PACK PER 365 4 AUTOINJECT ORS PER 28 2 BOXES (2 PREFILLED SYRINGES) PER FILL 2 SYRINGES (0.6 ML) PER 28 REMOVE ST FOR T/F OF AN ORAL AGENT ADD ST FOR A TD ESTROGEN 1 KIT EVERY 24 WEEKS ADD STEP THERAPY 9 TABLETS 3 TABLETS QL REVISED 750 GM PER

Page 5 of 5 MOVEMENT DISORDER MOVEMENT DISORDER SUBLINGUAL IMMUNTHERAPY TARGETED IMMUNE MODIFIERS AFREZZA 90 CARTRIDGES (12 UNIT) AFREZZA 180 CARTRIDGES (60X4 UNIT AND 60X8 UNIT AND 60X12 UNIT) FIASP, FIASP FLEXTOUCH HUMALOG JUNIOR KWIKPEN GOCOVRI ER 68.5 MG GOCOVRI ER 137 MG ODACTRA ENBREL MINI WITH AUTOTOUCH 3 BOXES PER 1 2 ADD PA AND QL 1 TABLET PER 4 CARTRIDGES PER 28 Please review these changes and work with your Anthem HealthKeepers Plus patients to transition them to formulary alternatives. If you determine formulary alternatives are not clinically appropriate for specific patients, you will need to obtain PA to continue coverage beyond the applicable effective date. We recognize the unique aspects of members cases. If your Anthem HealthKeepers Plus patient cannot be converted to a formulary alternative, call our Pharmacy department at 1-800-901-0020 and follow the voice prompts for pharmacy PA. You can find the Preferred Drug List (formulary) on our website at https://mediproviders.anthem.com/va. If you need assistance with any other item, contact your local Provider Relations representative or call Provider Services at 1-800-901-0020.